Related Experiment Video
Updated: Dec 10, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.9K
Baroreflex function in Parkinson's disease: insights from the modified-Oxford technique
Jeann L Sabino-Carvalho1, Roberta A Cartafina1, Gabriel M Guimarães1
1NeuroV̇ASQ̇ - Integrative Physiology Laboratory, University of Brasília, Brazil.
Journal of Neurophysiology
|September 3, 2020
Summary
Parkinson's disease (PD) patients show significantly reduced baroreflex gain, a key regulator of blood pressure and heart rate. This dysfunction, evident with specific testing, contributes to cardiovascular issues in PD.
Area of Science:
- Cardiovascular Physiology
- Neurodegenerative Diseases
Background:
- Nonmotor symptoms, including cardiovascular dysregulation, are prevalent in Parkinson's disease (PD).
- Baroreflex dysfunction is increasingly implicated as a mechanism underlying cardiovascular issues in PD, though direct evidence has been limited.
Purpose of the Study:
- To investigate whether baroreflex gain is attenuated in middle-aged patients with Parkinson's disease.
- To assess baroreflex function using the modified-Oxford technique across a wide range of the reflex arc.
Main Methods:
- Beat-to-beat heart rate and blood pressure were recorded in 11 PD patients and 7 age-matched controls.
- The modified-Oxford technique, involving sequential vasoactive drug boluses, was used to elicit blood pressure changes.
- Baroreflex gain was calculated using segmental linear regression and a symmetric sigmoid model, with spontaneous indices also analyzed.
Main Results:
- Baroreflex gain was significantly lower in PD patients compared to controls, by over 50% using both regression models (P = 0.003 and P = 0.009).
- Patients with PD exhibited a larger blood pressure operating range (P = 0.032).
- Gain calculated from spontaneous indices did not differ between groups, suggesting limitations in detecting dysfunction.
Conclusions:
- Cardiovagal baroreflex dysfunction is directly demonstrated in patients with Parkinson's disease.
- Attenuated baroreflex gain and an increased operating range may contribute to cardiovascular complications like orthostatic intolerance in PD.
- Specific cardiovascular challenges are necessary to reveal baroreflex impairments, as spontaneous measures may be insufficient.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Parkinson's Disease: Treatment
815
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
815
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K

